Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04867642
Status:
COMPLETED
Last Update Posted:
2023-03-30
First Post:
2021-04-27
Brief Title:
A Study to Test the Safety Tolerability and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinsons Disease
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Study Overview
Official Title:
A First-In-Human Randomized Participant-Blind Investigator-Blind Placebo-Controlled Single- and Multiple-Dose Dose-Escalating Study Evaluating the Safety Tolerability and Pharmacokinetics of UCB0022 in Healthy Participants and Participants With Parkinsons Disease
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate the safety tolerability and pharmacokinetic PK of UCB0022 and food effect
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None